1.A Method for the Localization of Normal Foramen of Monro in Korean.
Hyn Joo KIM ; Kyu Chang LEE ; Hun Jae LEE
Journal of Korean Neurosurgical Society 1976;5(1):45-49
It is well known that many investigators have devised the methods for the localization of foramen of Monro, considering it as an essential one in stereotactic brain surgery. They have made use of calcified pineal gland, pneumoencephalogram or calculation of the coordinates of the foramen of Monro by bone structures etc. But the complications brought about by the above mentioned methods and nonvisualization of the pineal gland have made them in complex to make exact localization of foramen of Monro. The author devised a new, simple method for the localization of foramen of Monro, using 20 cases of lateral view of pneumoencephalogram whose diagnoses were confirmed as idiopathic epilepsy. The results obtained are as follow : 1. The anterior margin of foramen of Monro is located on the line interconnecting the central point of sella turcica and inner table of the cranial vault with the angle of 86.2?.3? provided that the base line is supposed as the line interconnecting the central point of sella turcica and the internal occipital protuberance. 2. The length from the central point of sella turcica to the anterior margin of foramen of Monro is measured to be 3.5 not equal 0.2cm. 3. Approximately 0.3 is calculated from the ratio between the segment interconnecting the central point of sella turcica and the anterior margin of foramen of Monro, and the segment interconnecting the central point of sella turcica and inner table of skull through anterior margin of foramen of Monro.
Brain
;
Cerebral Ventricles*
;
Diagnosis
;
Epilepsy
;
Humans
;
Pineal Gland
;
Research Personnel
;
Sella Turcica
;
Skull
2.Interobserver Variability in the Assessment of Coronary Arteriogram: Comparison between Visual and Computer based Quantitative Estimation.
Young Dae KIM ; Il PARK ; Sun Taek KIM ; Hyn Guk DO ; Moo Hyun KIM ; Sung Jae JOO ; Chang Woon KANG ; Ki Hyun KIM ; Jong Seong KIM
Korean Circulation Journal 1993;23(6):857-866
BACKGROUND: Conventional visual assessment of coronary arteriogram is fraught with large interobserver variance and disagreement with pathologic findings. Thus quantitative coronary angiography had been recently developed to meet the requirement of more reproducible measurement of severity of coronary artery disease. This study was designed to evaluate the interobserver variability of quantitative coronary angiography and its usefulness in clinical application. METHODS: Three independent observers analysed coronary angiogram of 31 consecutive patients by visual assessment and quantitative measurement using computer based algorithm. RESULTS: 1) There was considerable disagreement between 3 observers in the identification of significant coronary stenosis. Complete agreement was achieved in only 29/61 (47%) coronary lesion and agreement of more than 2 observers in 41/61(67%) lesion. 2) In visual assessment, the largest interobserver variance was found in acute marginal artery and distal circumflex artery, whereas the least variance was observed in proximal right coronary artery. 3) The average interobserver variance was 13.1% in visual assessment, 14.9% in geometric analysis, and 10.5% in video densitometric analysis. There was no significant difference between these values. 4) Visual assessment was noted to overestimate the severity of stenotic lesion, by 5.6% compared to geometric analysis and by 11.8% compared to video-densitometric analysis. CONCLUSION: These findings suggest that identifying significant lesion is major source of interobserve variability in both visual and quantitative analysis of coronary arteriogram. In addition, suboptimal image quality was responsible for the inability of quantitative analysis to reduce the variance. These factors seem to be major limitation of quantitative coronary arterirogam.
Arteries
;
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Stenosis
;
Coronary Vessels
;
Humans
;
Observer Variation*
3.A Case of Large Left Atrial Myxoma Presenting as Atrial Flutter.
Ji Hyn LEE ; Gyu Won LEE ; O Kil KIM ; Jung Ho HUR ; Byoung Joo CHOI ; Kang Ju CHOI ; Tae Joon CHA ; Jae Woo LEE ; Hyun Su KIM
Journal of Cardiovascular Ultrasound 2008;16(2):59-62
Cardiac myxoma is the most common benign cardiac tumor and it presents various clinical symptoms and signs. Although two-thirds of patients have abnormal electrocardiographic findings, atrial flutter or conduction abnormalities are known to be rare. We report on a case of a large left atrial myxoma which was diagnosed by trans-thoracic, trans-esophageal echocardiography, chest computerized tomography, and histological examination. The myxoma was presented as atrial flutter in a 41-year old man who was complaining palpitation and dyspnea on exertion. After surgical excision of the mass, atrial flutter converted to normal sinus rhythm. We report this case with review of literatures on left atrial myxoma associated with arrhythmia.
Arrhythmias, Cardiac
;
Atrial Flutter
;
Dyspnea
;
Echocardiography
;
Electrocardiography
;
Heart Neoplasms
;
Humans
;
Myxoma
;
Thorax
4.A Case of Passive Smoking Induced Respiratory Bronchiolitis Associated Interstitial Lung Disease.
Kyoung Ju LEE ; Jung Ha KIM ; Eun Sil HA ; Jin Yong JUNG ; Seung Hyeun LEE ; Se Joong KIM ; Eun Joo LEE ; Gyu Young HUR ; Hye Cheol JUNG ; Sung Yong LEE ; Hyn Koo KIM ; Sang Yeub LEE ; Je Hyeong KIM ; Chol SHIN ; Jae Jeong SHIM ; Kwang Ho IN ; Kyung Ho KANG ; Se Hwa YOO
Tuberculosis and Respiratory Diseases 2005;59(5):541-545
Respiratory bronchiolitis associated interstitial lung disease is a rare condition among current or ex-smokers, which has features consistent with interstitial lung disease. The presentations are non-specific, but symptoms generally include a cough and dyspnea on exertion, and its pathology is characterized by the accumulation of pigmented macrophages within the respiratory bronchioles and adjacent air spaces, and is associated with mild thickening of the peribronchiolar interstitium. Recently, the case of a 54-year-old woman passive smoker, diagnosed as having respiratory bronchiolitis associated interstitial lung disease, was experienced at our institution.
Bronchioles
;
Bronchiolitis*
;
Cough
;
Dyspnea
;
Female
;
Humans
;
Lung Diseases, Interstitial*
;
Macrophages
;
Middle Aged
;
Pathology
;
Tobacco Smoke Pollution*
5.The Efficacy of Pre - operative Chamotherapy with Intra-arterial Cisplatin and Intravenous Adriamycin for High Grade Osteosarcoma.
Sun Young RHA ; Soo Jung GONG ; Hee Cheol CHUNG ; Kwang Yong SHIM ; Joong Bae AHN ; Nae Choon YOO ; Hyn Cheol CHUNG ; Joo Hang KIM ; Hae Kyung ROH ; Jin Sik MIN ; Byung Soo KIM ; Kyu Ho SHIN ; Woo Ick YANG ; Chong In LEE
Journal of the Korean Cancer Association 1999;31(1):134-143
PURPOSE: Osteosarcoma is one of the most common juvenile malignant tumors in Korea. Combined modality treatment [pre-operative chemotherapy + surgery (limb salvage or amputation) + adjuvant chemotherapy] had improved the overall survival and quality of life. To improve the local control rate, we introduced pre-operative chemotherapy combined with intra-arterial (IA) cisplatin and continuous intravenous infusion (CI) of adriamycin. We evaluated the efficacy and feasibility, such as limb salvage rate, recurrence pattern and the survival impact, based on the histologic response of pre-operative chemotherapy. MATERIALS AND METHODS: Fourty-one patients with histologically-proven high grade osteosarcoma of the extremities were enrolled from January 1990 to June 1996. Pre-operative chemotherapy, cisplatin 120 mg/m2 IA and adriamycin 75 mg/m2/72hrs CI, was administered for 3 cycles with 3 week interval, followed by surgery. Post-operative chemotherapy was applied by the tumor necrosis rate. If the tumor necrosis of the specimen was more than 90%, the same regimen af the preoperative one was administered for 3 cycles. A salvage regimen (Ifosfamide 7.5 gm/m2/5d IV + high dose MTX 10 gm/m2 IV VP-16 360 mg/m2/3d IV) was administered every 3 weeks for 6 cycles if the tumor necrosis was <90%. RESULTS: Of 41 patients, 37 were evaluable for efficacy and toxicities, because 4 refused further chemotherapy after 1 or 2 cycles. Twenty-one patients were male and 16 female, with the median age of 16 years (8-41). The tumor locations were as follows: distal femur 20, proximal tibia 8, humerus 6, distal tibia 2 and 1 in proximal femur. All but one patient, who died of neutropenic sepsis, completed the planned pre-operative therapy. Of the 36 patients who received surgery, limb salvage surgery was possible in 30 patients (83.3%) and 27 patients (75%) showed a good response (10 with grade III, 27.8%; 17 with grade IV, 47.2%). With a median follow-up of 23 months, 3-year disease-free survival rate was 54.7% and overall survival rate was 78.3%. Of the 15 patients who recurred, the major metastatic site was the lungs. No operation-related mortality was observed. Most patients experienced grade III-IV nausea, vomiting and hematologic toxicities, which were reversible with supportive care. CONCLUSION: Pre-operative chemotherapy combined with IA cisplatin and CI adriamycin induced higher good response rate without survival benefits. To improve the survival rate, the design of good salvage chemotherapy with a non-cross resistant regimen should be considered.
Cisplatin*
;
Disease-Free Survival
;
Doxorubicin*
;
Drug Therapy
;
Etoposide
;
Extremities
;
Female
;
Femur
;
Follow-Up Studies
;
Humans
;
Humerus
;
Infusions, Intravenous
;
Korea
;
Limb Salvage
;
Lung
;
Male
;
Mortality
;
Nausea
;
Necrosis
;
Osteosarcoma*
;
Quality of Life
;
Recurrence
;
Sepsis
;
Survival Rate
;
Tibia
;
Vomiting
6.Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites.
Ji Hye KIM ; Ji Ho LEE ; Young Min YE ; Jae Hyun LEE ; Jung Won PARK ; Gyu Young HUR ; Joo Hee KIM ; Hyn Young LEE ; Yoo Seob SHIN ; Eun Mi YANG ; Hae Sim PARK
Allergy, Asthma & Immunology Research 2018;10(6):675-685
PURPOSE: This study aims to determine the efficacy and safety of house dust mite (HDM)-sublingual immunotherapy (SLIT) in elderly patients with AR. METHODS: A total of 45 patients aged ≥ 60 years with HDM-induced AR who had ≥ 3 A/H ratio on skin prick test and/or ≥ 0.35 IU/L to both Dermatophagoides farinae and Dermatophagoides pteronyssinus by ImmunoCAP were enrolled in 4 university hospitals. To evaluate additional effects of HDM-SLIT, they were randomized to the SLIT-treated group (n = 30) or control group (n = 15). Rhinoconjunctivitis total symptom score (RTSS), rhinoscopy score, Korean rhinoconjunctivitis quality of life questionnaire, rhinitis control assessment test, asthma control test scores, and adverse reactions, were assessed at the first visit (V1) and after 1 year of treatment (V5); for immunological evaluation, serum levels of HDM-specific immunoglobulin A/IgE/IgG1/IgG4 antibodies and basophil response to HDMs were compared between V1 and V5 in both groups. RESULTS: There were no significant differences in demographics, RTSS, skin reactivity to HDMs, or serum total/specific IgE levels to HDMs (P < 0.05, respectively) between the 2 groups. Nasal symptom score and RTSS decreased significantly at year 1 in the 2 groups (P < 0.05). There were no significant differences in percent decrease in nasal symptom score and RTSS at year 1 between the 2 groups (P < 0.05); however, rhinoscopic nasal symptom score decreased significantly in the SLIT-treated group (P < 0.05). Immunological studies showed that serum specific IgA levels (not specific IgE/IgG) and CD203c expression on basophils decreased significantly at V5 in the SLIT-treated group (P = 0.011 and P = 0.001, respectively), not in the control group. The control group required more medications compared to the treatment group, but there were no differences in adverse reactions. CONCLUSIONS: It is suggested that HDM-SLIT for 1 year could induce symptom improvement and may induce immunomodulation in elderly rhinitis patients.
Aged*
;
Antibodies
;
Asthma
;
Basophils
;
Demography
;
Dermatophagoides farinae
;
Dermatophagoides pteronyssinus
;
Dust*
;
Hospitals, University
;
Humans
;
Immunoglobulin A
;
Immunoglobulin E
;
Immunoglobulins
;
Immunomodulation
;
Immunotherapy
;
Pyroglyphidae*
;
Quality of Life
;
Rhinitis*
;
Rhinitis, Allergic
;
Skin
;
Sublingual Immunotherapy*